CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $268.27M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 2.7: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
1.14%
Annual Rate
CNY 0.25Paid unknown
Payout Ratio
147.1%High
Payback Period
95.8 yr
Last Ex-Dividend
Jun 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.80BCNY268.27M · vs all stocks (USD)
Trailing P/E
136.94xvs Medical Instruments & Supplies peers
Revenue (TTM)
497.13MCNY74.21M · vs all stocks (USD)
Profit Margin
2.61%vs Medical Instruments & Supplies peers
Beta
0.3100xvs all stocks
52-Week Change
8.89%vs all stocks
Forward Annual Dividend Yield
1.14%vs all stocks
Market Capitalization
1.80BCNY268.27M · vs all stocks (USD)
Enterprise Value
1.84BCNY275.24M · vs all stocks (USD)
Trailing P/E
136.94xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.62xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.38xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.71xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
60.80xvs Medical Instruments & Supplies peers
Gross Margin
42.00%vs Medical Instruments & Supplies peers
Profit Margin
2.61%vs Medical Instruments & Supplies peers
Operating Margin
9.18%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.22%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.77%vs Medical Instruments & Supplies peers
Revenue (TTM)
497.13MCNY74.21M · vs all stocks (USD)
Revenue per Share (TTM)
6.82CNYUpdated Sep 22, 2026Quarterly Revenue Growth
93.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
240.11MCNY35.84M · vs all stocks (USD)
EBITDA (TTM)
66.76MCNY9.97M · vs all stocks (USD)
Net Income (TTM)
12.98MCNY1.94M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
58.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
76.67MCNY11.44M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-23.45MCNY-3.50M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2500CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
1.14%vs all stocks
Trailing Annual Dividend Rate
0.2500CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.14%vs all stocks
Payout Ratio
147.12%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
18.30MCNYFY2025 · Dec 31, 2025Revenue
441.78MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
224.26MCNYFY2025 · Dec 31, 2025Gross Profit
217.52MCNYFY2025 · Dec 31, 2025Operating Income
43.09MCNY6.43M · vs all stocks (USD)
Pre-tax Income
17.22MCNYFY2025 · Dec 31, 2025Income Tax Expense
-2.59MCNYFY2025 · Dec 31, 2025Net Income
19.81MCNYFY2025 · Dec 31, 2025EBIT
24.00MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
66.76MCNYFY2025 · Dec 31, 2025Research & Development
60.07MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
50.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.78MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
74.25MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
74.25MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
19.81MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.25MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
40.98MCNYFY2025 · Dec 31, 2025Free Cash Flow
-20.98MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
105.72MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
19.81MCNYFY2025 · Dec 31, 2025Other Non-cash Items
9.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
24.36MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-12.95MCNYFY2025 · Dec 31, 2025Capital Expenditures
-61.96MCNYFY2025 · Dec 31, 2025Purchase of Investments
-132.58MCNYFY2025 · Dec 31, 2025Sale of Investments
98.25MCNYFY2025 · Dec 31, 2025Other Investing Activity
-558.57KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-96.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
161.11MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-217.52MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-6.83MCNYFY2025 · Dec 31, 2025Other Financing Charges
11.89KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-63.22MCNYFY2025 · Dec 31, 2025Shares Outstanding
77.20MSharesUpdated Sep 22, 2026Float Shares
44.40MSharesUpdated Sep 22, 2026% Held by Insiders
48.20%vs all stocks
% Held by Institutions
7.62%vs all stocks
Total Cash (MRQ)
190.38MCNY28.42M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.41CNYUpdated Sep 22, 2026Total Debt (MRQ)
175.56MCNY26.21M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2223xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.48xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
9.77CNYUpdated Sep 22, 2026Total Assets
1.39BCNY206.80M · vs all stocks (USD)
Total Current Assets
750.37MCNYFY2025 · Dec 31, 2025Total Liabilities
584.84MCNYFY2025 · Dec 31, 2025Total Non-current Assets
635.01MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
51.46MCNYFY2025 · Dec 31, 2025Total Current Liabilities
533.39MCNYFY2025 · Dec 31, 2025Cash
99.88MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.12MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
123.00MCNYFY2025 · Dec 31, 2025Other Short-term Investments
44.86MCNYFY2025 · Dec 31, 2025Accounts Receivable
277.78MCNYFY2025 · Dec 31, 2025Inventory
89.83MCNYFY2025 · Dec 31, 2025Accounts Payable
212.33MCNYFY2025 · Dec 31, 2025Short-term Debt
149.44MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.00MCNYFY2025 · Dec 31, 2025Long-term Debt
35.00MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
15.78MCNYFY2025 · Dec 31, 2025Common Stock (Book)
77.20MCNYFY2025 · Dec 31, 2025Retained Earnings
287.61MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
800.54MCNY119.50M · vs all stocks (USD)
Treasury Stock
22.50MCNYFY2025 · Dec 31, 202552-Week Low
15.30CNYUpdated Sep 22, 202652-Week High
32.40CNYUpdated Sep 22, 202652-Week Change
8.89%vs all stocks
Beta
0.3100xvs all stocks
50-Day MA
19.98CNYUpdated Sep 22, 2026200-Day MA
22.88CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.39MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.41MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1700CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.47Dividend per Share: 0.25Earnings per Share: 0.17
High gross margins eroded by operating costsNotable
Gross Margin: 0.42Profit Margin: 0.03
Financial Health
Altman Z-Score 2.7: safe zoneNotable
Altman Z-Score: 2.70
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $268.27M, lower than 95% of all stocks globallySignificant
Market cap (USD): 268,270,432.32Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Piolax Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Okabe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hokko Chemical Industry Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Youlchon Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Batiçim Batı Anadolu Çimento Sanayii A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dah San Electric Wire & Cable Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hangzhou iEcho Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Textile Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huaiji Dengyun Auto Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eg Industries Bhd
Tier 1ProductionThroughput-Bound ConversionFlowRule